AI Buyer Insights:

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

List of Inetum GenAI Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Air Liquide Medical Systems Manufacturing 410 $130M France Inetum Inetum GenAI Generative AI Platforms 2024 n/a
In 2024, Air Liquide Medical Systems implemented Inetum GenAI, a Generative AI Platforms application developed by Inetum and built on Azure OpenAI to accelerate responses to commercial invitations to tender. The deployment targets tender workflows for fans, supplies and maintenance within Air Liquide Medical Systems, a subsidiary of Air Liquide Healthcare Medtech, and is positioned to support commercial teams and employees who prepare bid responses for end customers such as hospitals. Inetum GenAI was configured with three primary functional modules, document requirement extraction, knowledge search, and answer generation. The solution performs automatic extraction of all requirements from invitations to tender linked to fans, supplies or maintenance, searches an internal knowledge base developed by Air Liquide for relevant sources, and proposes drafted answers for employees to review and adapt, enabling a sourced response base for bid authors. Architecturally the solution is cloud oriented, leveraging Azure OpenAI as the generative model backbone, with integration into Air Liquide’s internally developed knowledge repository to surface cited source material during generation. Inetum is responsible for developing and operating the generative AI technologies, and the implementation connects tender intake and content processing to the knowledge search and response drafting modules used by commercial staff. Governance and operational impacts were defined around bid response efficiency and quality of outputs, the implementation is intended to reduce response times from the usual dozens of days to an almost instantaneous sourced response baseline, simplify procedures and free staff from time consuming tasks in favor of higher value assignments. Inetum’s role covers development and exploitation of the Generative AI Platforms capability for Air Liquide Medical Systems, with the system used to standardize tender handling workflows and centralize sourced answers for employee use.
Est Ensemble Government 2000 $465M France Inetum Inetum GenAI Generative AI Platforms 2024 n/a
In 2024, Est Ensemble implemented Inetum GenAI, a Generative AI Platforms solution, to optimize operational and administrative processes and to facilitate the processing of tender applications. Est Ensemble deployed Inetum GenAI to support procurement and contract award business functions across the territorial public establishment in the Greater Paris metropolitan area. Inetum GenAI is delivered with a set of functional modules developed for Est Ensemble, including automatic verification of candidate eligibility such as certifications, automated completion of bidder files, assistance in evaluating the relevance of submitted answers, and drafting of objective rating commentary. The project includes a planned second phase to add module capabilities for side by side comparison of bidders responses against defined evaluation criteria, and an eventual chatbot to let agents query bidder responses directly. Inetum was selected to develop and operate the AI generative technologies, indicating a managed deployment model with centralized platform operation for Est Ensemble agents. The solution is intended for operational use by procurement and administrative teams, and the vendor committed to have the tool in place by the summer with operational implementation before the end of 2024. Governance changes focus on embedding the Inetum GenAI workflow into existing tender evaluation processes, shifting manual verification and document search tasks toward the platform while keeping final decision and oversight within established procurement authorities. Est Ensemble expects the Generative AI Platforms deployment to accelerate evaluation cycles, enabling reviewers to assess bids in a few dozen minutes rather than the usual several days, and to free staff to concentrate on higher value administrative and user service activities.
Showing 1 to 2 of 2 entries

Buyer Intent: Companies Evaluating Inetum GenAI

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Inetum GenAI. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Inetum GenAI for Generative AI Platforms include:

  1. NewtonX, a United States based Professional Services organization with 250 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Inetum GenAI Coverage

Inetum GenAI is a Generative AI Platforms solution from Inetum.

Companies worldwide use Inetum GenAI, from small firms to large enterprises across 21+ industries.

Organizations such as Est Ensemble and Air Liquide Medical Systems are recorded users of Inetum GenAI for Generative AI Platforms.

Companies using Inetum GenAI are most concentrated in Government and Manufacturing, with adoption spanning over 21 industries.

Companies using Inetum GenAI are most concentrated in France, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Inetum GenAI across Americas, EMEA, and APAC.

Companies using Inetum GenAI range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 50%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 0%.

Customers of Inetum GenAI include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Inetum GenAI customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Generative AI Platforms.